5885
Herein , we describe 2 patients who developed unusual CD8 + cutaneous lymphoproliferative disorders after treatment with efalizumab and infliximab .
 CD8 + cutaneous lymphoproliferative disorders, efalizumab; CD8 + cutaneous lymphoproliferative disorders, infliximab
Please list all entity pairs containing a certain relationship in the given options.Output format is "word1, word2; word3, word4". 
Option: adverse effect 
Text: {0} 
Answer:
 CD8 + cutaneous lymphoproliferative disorders, efalizumab; CD8 + cutaneous lymphoproliferative disorders, infliximab